Absent of any other stock-moving news, a 25% increase in an analyst's price target for Teladoc (NYSE: TDOC) got the stock ...

Shares of Teladoc Health (NYSE:TDOC) rose ~7% premarket Tuesday after Jefferies cited a short-term opportunity in the ...

The Dallas-based specialty care platform, valued at $1 billion in 2023 and now rebranded as Lantern, has expanded its ...

At the time, Teladoc Health was hailed as the ultimate telemedicine darling; its stock price skyrocketed to nearly $300 per ...

Teladoc Health’s TDOC shares rose nearly 12% on Tuesday after Jefferies raised its price target from $8 to $10 per share.

Let’s dig into the relative performance of Teladoc (NYSE:TDOC) and its peers as we unravel the now-completed Q2 online marketplace earnings season.

Teladoc Health is one of the stocks that had a crazy run during COVID and then fell hard. See what makes TDOC a potential ...

Employers have an incentive to help their employees live healthier lives: healthy employees are more productive, and have ...

Analyst Allen Lutz of Bank of America Securities reiterated a Hold rating on Teladoc (TDOC – Research Report), retaining the price target ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.57, a high estimate of ...

Founded in 2017, Hims & Hers originally specialized in selling over-the-counter medications and personal care products through its online platform as well as brick-and-mortar retailers such as Target.

Glen Santangelo, an analyst from Jefferies, assigned the Hold rating on Teladoc (TDOC – Research Report). The associated price target is ...